Initial experience with regadenoson as a pharmacologic stress agent for myocardial perfusion imaging post FDA approval

被引：0
|
作者：
Majmundar, H. [1 ]
Coats, N. P. [1 ]
Vernotico, S. [1 ]
Doan, J. H. [1 ]
Hernandez, T. M. [1 ]
Evini, M. [1 ]
Hepner, A. D. [1 ]
Ip, T. K. [1 ]
Miyamoto, M. I. [1 ]
Thomas, G. S. [1 ]
机构：
[1] Mission Internal Med Grp, Mission Viejo, CA USA
来源：
EUROPEAN HEART JOURNAL SUPPLEMENTS | 2011年 / 13卷 / 0A期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
286
引用
收藏
页码：A59 / A60
页数：2
相关论文
共 50 条
  • [41] CME Instructions: Comparison of hemodynamic and stress testing variables in patients undergoing regadenoson stress myocardial perfusion imaging to regadenoson with adjunctive low-level exercise myocardial perfusion imaging
    Journal of Nuclear Cardiology, 2013, 20 (3) : 334 - 335
  • [42] The prognostic value of regadenoson myocardial perfusion imaging
    Fadi G. Hage
    Gopal Ghimire
    Davis Lester
    Joshua Mckay
    Steven Bleich
    Stephanie El-Hajj
    Ami E. Iskandrian
    Journal of Nuclear Cardiology, 2015, 22 : 1214 - 1221
  • [43] Erratum to: Regadenoson for myocardial perfusion imaging: Is it safe?
    Fadi G. Hage
    Journal of Nuclear Cardiology, 2014, 21 : 1266 - 1266
  • [44] The prognostic value of regadenoson myocardial perfusion imaging
    Hage, Fadi G.
    Ghimire, Gopal
    Lester, Davis
    Mckay, Joshua
    Bleich, Steven
    El-Hajj, Stephanie
    Iskandrian, Ami E.
    JOURNAL OF NUCLEAR CARDIOLOGY, 2015, 22 (06) : 1214 - 1221
  • [45] Performance and safety profile of regadenoson myocardial perfusion imaging: first experience in Greece
    Koutsikos, John
    Angelidis, George
    Zafeirakis, Athanasios
    Mamarelis, Ioannis
    Vogiatzis, Merkourios
    Ilia, Eliverta
    Lazaridis, Kyriakos
    Demakopoulos, Nikolaos
    HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2017, 20 (03): : 232 - 236
  • [46] FDA approves pharmacologic stress agent
    Thompson, Cheryl A.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2008, 65 (10) : 890 - 890
  • [47] Cardiovascular outcomes after pharmacologic stress myocardial perfusion imaging
    Lee, Douglas S.
    Husain, Mansoor
    Wang, Xuesong
    Austin, Peter C.
    Iwanochko, Robert M.
    AMERICAN HEART JOURNAL, 2016, 174 : 138 - 146
  • [48] Safety and efficacy of Regadenoson in myocardial perfusion imaging (MPI) stress tests: A review
    Ahmed, Ambereen
    QUANTITATIVE PHASE IMAGING IV, 2018, 10503
  • [49] THE PROGNOSTIC VALUE OF REGADENOSON STRESS MYOCARDIAL PERFUSION IMAGING: THE LARGEST COHORT TO DATE
    Kattoor, Ajoe
    Iskander, Mina
    Iskander, Fady
    Khan, Rozi
    Doukky, Rami
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 1578 - 1578
  • [50] Impact of exercise on regadenoson side effects during myocardial perfusion stress imaging
    Khandekar, Shashi
    Kwon, Deborah
    Brunken, Richard
    Cerqueira, Manuel
    Jaber, Wael
    Young, Ron
    Menon, Venu
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50
12345